
PreludeDx
@preludedx
Developers of DCISionRT, the first biological risk signature designed specifically for ductal carcinoma in situ (DCIS).
Your Biology, Your Decision®
ID: 935917226443530240
http://www.preludedx.com 29-11-2017 17:03:50
634 Tweet
250 Followers
339 Following


















2/4 Hannah Storm sportscaster and #DCIS survivor, shares a few things she wishes she knew when first diagnosed—like the availability of the latest testing to help tailor treatment just for you. Her story brings hope and actionable advice during #BreastCancerAwarenessMonth

